Pure Global AI
CDSCO UID MFG/IVD/2020/000082_ee5de77f691245d1e917a85990e704cf_6271544e872ff56f02167ae0e1c4bc3c

CK-MB Test Kit

Biogenix Inc. Pvt. Ltd.Device Class Class BIndia CDSCOBrand: BIOGENIX
VerifiedCDSCO · official registry
Registration details
UID
MFG/IVD/2020/000082_ee5de77f691245d1e917a85990e704cf_6271544e872ff56f02167ae0e1c4bc3c
Device class
Class B
Brand name
BIOGENIX
Approving authority
Uttar Pradesh
Product information
CK-MB is Dry fluorescence Immunoassay for the quantitative determination of Creatine Kinase Isoenzyme-MB (BIOGENIX) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (BIOGENIX) and acute coronary syndrome (BIOGENIX)
About this record

CK-MB Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000082_ee5de77f691245d1e917a85990e704cf_6271544e872ff56f02167ae0e1c4bc3c. This device is marketed under the brand name BIOGENIX. The license holder is Biogenix Inc. Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Uttar Pradesh.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.